Financial Costs of the Zanzibar Elimination of Schistosomiasis Transmission Project.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 1 10 2020
medline: 5 1 2021
entrez: 30 9 2020
Statut: ppublish

Résumé

We estimated the financial costs of different interventions against urogenital schistosomiasis, implemented by the Zanzibar Elimination of Schistosomiasis Transmission (ZEST) project, on Pemba and Unguja islands, Tanzania. We used available data on project activities, resources used, and costs reported in the accounting information systems of ZEST partners. The costs were estimated for all the activities related to snail control, behavior change interventions, the impact assessment surveys, and management of the whole program. Costs are presented in US$ for the full duration of the ZEST project from 2011/2012 to 2017. The total financial costs of implementing snail control activities over 5 years, excluding the costs for donated Bayluscide, were US$55,796 on Pemba and US$73,581 on Unguja, mainly driven by personnel costs. The total financial costs of implementing behavior change activities were US$109,165 on Pemba and US$155,828 on Unguja, with costs for personnel accounting for 47% on Pemba and 69% on Unguja. Costs of implementing biannual mass drug administration refer to the estimated 2.4 million treatments provided on Pemba over 4 years (2013-2016), and do not include the costs of donated praziquantel. The total cost per provided treatment was, on average, US$0.21. This study showed the value of exploiting administrative data to estimate costs of major global health interventions. It also provides an evidence base for financial costs and main cost drivers of implementing multiple combinations of intervention sets that inform decisions regarding the feasibility and affordability of implementing schistosomiasis control and elimination strategies.

Identifiants

pubmed: 32996446
doi: 10.4269/ajtmh.20-0252
pmc: PMC7695112
doi:

Substances chimiques

Anthelmintics 0
Praziquantel 6490C9U457

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2260-2267

Références

PLoS Negl Trop Dis. 2020 Mar 30;14(3):e0008098
pubmed: 32226008
Wellcome Open Res. 2020 Mar 13;5:45
pubmed: 32587899
Health Policy Plan. 2008 Jan;23(1):24-35
pubmed: 18024966
PLoS Negl Trop Dis. 2011 Oct;5(10):e1326
pubmed: 22022622
Am J Trop Med Hyg. 1990 Sep;43(3):289-95
pubmed: 2121056
PLoS Negl Trop Dis. 2016 Jul 11;10(7):e0004814
pubmed: 27399310
Bull World Health Organ. 1990;68(6):721-30
pubmed: 2127381
Adv Parasitol. 2015 Mar;87:329-417
pubmed: 25765199
PLoS Negl Trop Dis. 2013 Oct 17;7(10):e2474
pubmed: 24147165
Acta Trop. 2013 Nov;128(2):412-22
pubmed: 21586268
PLoS Negl Trop Dis. 2019 May 6;13(5):e0007268
pubmed: 31059495
Parasit Vectors. 2015 Jul 03;8:355
pubmed: 26137945
Trop Med Parasitol. 1989 Jun;40(2):189-94
pubmed: 2505381
PLoS Negl Trop Dis. 2018 Mar 13;12(3):e0006250
pubmed: 29534061
Lancet Glob Health. 2019 Aug;7(8):e1118-e1129
pubmed: 31255591
Trop Med Int Health. 2010 May;15(5):614-8
pubmed: 20214757
Am J Trop Med Hyg. 2020 Jul;103(1_Suppl):58-65
pubmed: 32400354
Am J Trop Med Hyg. 2020 Jul;103(1_Suppl):66-79
pubmed: 32400353
BMC Public Health. 2012 Oct 30;12:930
pubmed: 23110494
J Biosoc Sci. 2016 Sep;48 Suppl 1:S56-73
pubmed: 27428066
PLoS Negl Trop Dis. 2015 Sep 11;9(9):e0004056
pubmed: 26360917
Lancet Glob Health. 2015 Oct;3(10):e629-38
pubmed: 26385302
Acta Trop. 2016 Nov;163:142-8
pubmed: 27498244
PLoS Negl Trop Dis. 2013 Nov 07;7(11):e2446
pubmed: 24244762
Trans R Soc Trop Med Hyg. 2009 Oct;103(10):1031-44
pubmed: 19409588
Health Econ. 2016 Feb;25 Suppl 1:53-66
pubmed: 26763594
Trends Parasitol. 2014 Dec;30(12):562-70
pubmed: 25455565
PLoS Negl Trop Dis. 2017 Jan 19;11(1):e0005289
pubmed: 28103243
East Afr Med J. 1965 Jan;42:1-9
pubmed: 14271180
Ann Trop Med Parasitol. 2011 Dec;105(8):537-47
pubmed: 22325813
PLoS Negl Trop Dis. 2017 Sep 26;11(9):e0005934
pubmed: 28949987

Auteurs

Paola Salari (P)

1Swiss Tropical and Public Health Institute, Basel, Switzerland.
2University of Basel, Basel, Switzerland.

Thomas Fürst (T)

1Swiss Tropical and Public Health Institute, Basel, Switzerland.
2University of Basel, Basel, Switzerland.

Stefanie Knopp (S)

1Swiss Tropical and Public Health Institute, Basel, Switzerland.
2University of Basel, Basel, Switzerland.

David Rollinson (D)

3Natural History Museum, London, United Kingdom.

Fatma Kabole (F)

4Neglected Diseases Program, Zanzibar Ministry of Health, Zanzibar, Tanzania.

Mohammed I Khamis (MI)

4Neglected Diseases Program, Zanzibar Ministry of Health, Zanzibar, Tanzania.

Mussa A Omar (MA)

5Public Health Laboratory-Ivo de Carneri, Chake Chake, Tanzania.

Oliver Bacon (O)

3Natural History Museum, London, United Kingdom.

Said M Ali (SM)

5Public Health Laboratory-Ivo de Carneri, Chake Chake, Tanzania.

Jürg Utzinger (J)

1Swiss Tropical and Public Health Institute, Basel, Switzerland.
2University of Basel, Basel, Switzerland.

Fabrizio Tediosi (F)

1Swiss Tropical and Public Health Institute, Basel, Switzerland.
2University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH